We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Strong Presubmission Process Key to Successful De Novo Bid: U.S.
Strong Presubmission Process Key to Successful De Novo Bid: U.S.
Makers of low and moderate risk devices can now use the U.S. Food and Drug Administration’s de novo pathway to gain approval without first filing for 510(k) clearance — a route the agency hopes devicemakers will take.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor